Read More Pharma Industry News GSK wins approval in China for Nucala in eosinophilic COPD, expanding respiratory biologics reach Find out how GSK’s Nucala just became the first biologic approved for eosinophilic COPD in China—and what it means for the future of respiratory care. byVenkateshJanuary 7, 2026